A Randomised, Controlled Clinical Trial Evaluating Changes in Therapeutic Efficacy and Oxidative Parameters after Treatment with Propionyl L-Carnitine in Patients with Peripheral Arterial Disease Requiring Haemodialysis

Authors: Salvatore Santo Signorelli,1; Fatuzzo, Pasquale2; Rapisarda, Francesco2; Neri, Sergio3; Ferrante, Margherita4; Gea Oliveri Conti,4; Fallico, Roberto4; Luigi Di Pino,1; Pennisi, Giuseppe1; Celotta, Gabriella1; Anzaldi, Massimiliano1

Source: Drugs & Aging, Volume 23, Number 3, 2006 , pp. 263-270(8)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $62.95 plus tax (Refund Policy)

Abstract:

Objective: We explored the efficacy of intravenous therapy with propionyl L-carnitine in patients with both peripheral arterial disease (PAD) and chronic renal insufficiency requiring haemodialysis.

Methods: The trial was a randomised, double-blind, placebo-controlled trial. Sixty-four patients on haemodialysis (32 per treatment arm) with chronic renal insufficiency and PAD were assigned to receive either intravenous propionyl L-carnitine 600mg or placebo 3 times weekly for 12 months. The main outcome measures were the ankle/brachial index (ABI), plasma malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) concentrations, and the plasma nitrite/nitrate ratio (NO2/NO3); these were measured at baseline and at 6 and 12 months.

Results: Significant increases in ABI were observed in the propionyl L-carnitine group, whereas in the placebo group the reverse trend was seen. In patients treated with propionyl L-carnitine, significant progressive decreases were seen in plasma MDA, 4-HNE and the NO2/NO3 ratio from baseline. In the placebo-treated group, only weakly significant or no differences were seen.

Conclusion: Intravenous administration of propionyl L-carnitine to haemodialysis patients with PAD improves both haemodynamic flow and the oxidative profile.

Keywords: Peripheral arterial disorders; Propionyl carnitine

Document Type: Research article

Affiliations: 1: 1 Department of Internal Medicine and Systemic Pathology, Medical Angiology Section, University of Catania, Catania, Italy 2: 2 Department of Internal Medicine and Systemic Pathology, Kidney Disease Section, University of Catania, Catania, Italy 3: 3 Department of Internal Medicine and Systemic Pathology, Internal Medicine Section, University of Catania, Catania, Italy 4: 4 Department of Anatomy, Diagnostic Pathology, Legal Medicine and Public Health Faculty of Medicine, University of Catania, Catania, Italy

Publication date: 2006-01-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page